What is the optimal treatment for suicidal ideation in adults?

Optimal Treatment for Suicidal Ideation in Adults

Cognitive behavioral therapy specifically designed for suicide prevention is the first-line psychotherapy and should be initiated immediately, as it reduces both suicide attempts and suicidal ideation with the strongest evidence base. 1, 2, 3

Immediate Safety Assessment and Intervention

• Remove all lethal means from the environment immediately—firearms (the leading method of suicide death), medications, and other dangerous items must be secured or removed under third-party supervision. 1, 4

• Establish continuous monitoring by a responsible adult until psychiatric evaluation is completed, particularly for patients with explicit intent to die, persistent wish to die, abnormal mental state, prior attempts, or lack of adequate support. 4, 5

• Assess multiple risk domains systematically: history of self-directed violence, current suicidal thoughts with plan and intent, psychiatric symptoms (agitation, hopelessness, impulsivity), comorbid substance use disorders, and access to lethal means. 4

First-Line Psychotherapy Interventions

• Cognitive behavioral therapy for suicide prevention (CBT-SP) is the psychotherapy of choice, with moderate-quality evidence showing reduction in both suicide attempts and suicidal ideation compared to treatment as usual. 1, 2, 3

• A 2024 randomized trial demonstrated that brief CBT for inpatients reduced suicide attempts by 60% over 6 months post-discharge (number needed to treat = 7) and reduced psychiatric readmissions by 71% in patients without substance use disorders. 2

• Dialectical behavior therapy (DBT) shows promise for reducing self-harm frequency and suicidal ideation, though the 2024 VA/DoD guidelines note insufficient evidence to make a definitive recommendation for or against its use. 1, 3

Pharmacotherapy: Condition-Specific Approaches

For Patients with Schizophrenia or Schizoaffective Disorder

• Clozapine is the only antipsychotic with evidence for reducing suicide attempts and should be offered to patients with schizophrenia or schizoaffective disorder who have suicidal ideation or a history of suicide attempts. 1, 6

For Patients with Bipolar Disorder

• Lithium is the cornerstone of long-term management for bipolar disorder with suicidal features, as it reduces suicide attempts 8.6-fold and is the only medication with strong evidence for reducing suicide risk in bipolar disorder. 4, 6

• Discontinuing lithium increases suicide attempt rates 7-fold and suicide completion rates 9-fold, making careful maintenance critical. 4

• Critical caveat: The 2024 VA/DoD guidelines downgraded lithium from "weak for" to "insufficient evidence" for reducing suicide or suicide attempts even in adults with mood disorders, creating a guideline conflict. 1, 5 However, the American Academy of Child and Adolescent Psychiatry maintains lithium as first-line based on adult data showing marked reductions in completed suicides. 4

For Acute Suicidal Ideation in Major Depressive Disorder

• Ketamine infusion (0.5 mg/kg IV over 30-45 minutes) can be offered as adjunctive treatment for short-term reduction in suicidal ideation in patients with major depressive disorder and active suicidal ideation. 1, 7, 8

• The effect is rapid (within 4 hours) but short-lived (up to 72 hours maximum), requiring a plan for sustained treatment. 7, 8

• Important limitation: There is insufficient evidence that ketamine reduces actual suicide attempts or completed suicides—only suicidal ideation. 1

• Ketamine requires intensive monitoring for blood pressure, dissociative effects, and respiratory depression, and carries risks of abuse potential and psychotomimetic symptoms. 9, 7

For Patients with Major Depressive Disorder

• SSRIs are first-line pharmacotherapy when major depressive disorder is the primary diagnosis, but they do not directly treat suicidality. 5

• Intensive monitoring is mandatory during the first 4-6 weeks of SSRI therapy, with weekly visits to assess for emergent suicidal ideation, behavioral activation, or akathisia. 5

• The absolute risk of SSRI-induced suicidal ideation is low (≈1% with treatment vs 0.2% with placebo; number needed to harm = 143), while the number needed to treat for clinical response is ≈3. 5

Safety Planning and Follow-Up

• Develop a comprehensive written safety plan that includes: specific warning signs and triggers for suicidal ideation, concrete coping strategies, responsible social supports, professional support contacts, and lethal means restriction counseling. 4

• Send periodic caring communications (postal mail, text messages) for 12 months following hospitalization to reduce suicide attempt risk. 1, 4

• Close clinical supervision is essential, particularly during the first year after discharge when risk is highest. 4

Digital and Community Interventions

• Self-guided digital interventions (app or web-based) that include cognitive behavioral therapeutic content may provide short-term reduction in suicidal ideation, though evidence is limited. 1

• Multicomponent community interventions that include training on mental health topics, local networking, and providing suicide prevention materials are weakly recommended. 1

Critical Practices to Avoid

• Do not rely on "no-suicide contracts"—their efficacy is unproven and they create false reassurance. 5

• Do not prescribe benzodiazepines or phenobarbital to suicidal patients, as these reduce self-control and increase disinhibition. 4, 5

• Do not prescribe tricyclic antidepressants as first-line treatment due to high lethality in overdose. 5

• Do not underestimate impulsivity—many suicide attempts occur within minutes of the decision. 4